Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The purpose of this study, entitled "Psychological trauma, post-traumatic stress disorder, and resilience in adults with congenital heart disease in a large population sample", is to evaluate for exposures during a lifetime with congenital heart disease that may be associated with higher likelihood of developing PTSD. Primary aim: \- Identify individual patient characteristics (medical, psychosocial, socioeconomic, etc.) that are associated with a diagnosis of PTSD. Secondary aims: * Calculate the prevalence of those meeting PTSD criteria in the ACHD population using the "gold standard" diagnostic clinician interview, while using the same data to validate a PTSD screening self-report survey in the ACHD population. * Determine the role of resilience in ACHD patients using a validated screening survey to assess its protective role toward PTSD. Hypotheses: * There are certain exposures (e.g. post-surgical pain, ICU delirium, bullying due to CHD) that are associated with a higher incidence and odds of meeting PTSD criteria. * "Gold standard" diagnostic interviews will most accurately estimate the prevalence of PTSD in ACHD which has been overestimated on prior screening-based studies, although the scope of the problem is still great. * Patients with a higher resilience score will show an association with a lower risk of PTSD.

Who May Be Eligible (Plain English)

Who May Qualify: - Congenital heart disease diagnosis, age \>= 18 years - Enrolled in CHI registry - English proficiency for survey completion - Access to an internet connection. Can be via computer or handheld device. Who Should NOT Join This Trial: - Any who opt out - Age \< 18 years - No diagnosis of congenital heart disease - Not enrolled in CHI registry/unable to access Internet Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Congenital heart disease diagnosis, age \>= 18 years * Enrolled in CHI registry * English proficiency for survey completion * Access to an internet connection. Can be via computer or handheld device. Exclusion Criteria: * Any who opt out * Age \< 18 years * No diagnosis of congenital heart disease * Not enrolled in CHI registry/unable to access Internet

Treatments Being Tested

BEHAVIORAL

Other

Surveys will be distributed for data collection. A subset of patients will participate in diagnostic clinician interviews. No interventions will be tested.

Locations (3)

Children's National Medical Center
Washington D.C., District of Columbia, United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
Nationwide Children's Hospital
Columbus, Ohio, United States